Alternatives to Transfusion: Perioperative Blood Management

Rossi's Principles of Transfusion Medicine: Fourth Edition

Volumn , Issue , 2009, Pages 566-574

  Uhl, Lynne ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 71849085543     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303513.ch37     Document Type: Chapter

References (66)

1. Goodnough LT, Shander A. Blood management. Arch Pathol Lab Med 2007;131:695-701.
2. Kruskall MS. Autologous blood collection and transfusion in a tertiary care center. In: Pineda AA, Taswell HF, editors. Autologous transfusion and hemotherapy. Boston, MA: Blackwell, 1991:53-77.
3. Kruskall MS. The changing face of transfusion practices: Autologous blood and other alternatives to routine transfusion. Transfus Sci 1989;10:77-8.
4. Menitove JE. Transfusion practices in the 1990s. Annu Rev Med 1991;42:297-309.
5. Nicholls MD, Janu MR, Davies VJ, Wedderburn CE. Autologous blood transfusion for elective surgery. Med J Aust 1986;144:396-9.
6. Brecher ME, Goodnough LT. The rise and fall of peroperative autologous blood donation. Transfusion 2002;42:1618-22.
7. Goldman M, Savard R, Long A, et al. Declining value of preoperative autologous donation. Transfusion 2002;42:819-23.
8. Rock G, Berger R, Bormanis J, et al. A review of nearly two decades in an autologous blood programme: The rise and fall of activity. Transfus Med 2006;16:307-11.
9. Department of Health and Human Services. The 2007 National Blood Collection and Utilization Survey Report. Washington, DC: DHHS, 2008.
10. Henry DA, Carless PA, Moxey AJ, et al. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2002;(2):CD003602.
11. Faught C, Wells P, Fergusson D, Laupacis A. Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature. Transfus Med Rev 1998;12:206-25.
12. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am 2002;8:1299-304.
13. Blajchman MA. Landmark studies that have changed the practice of transfusion medicine. Transfusion 2005;45:1523-30.
14. Goodnough LT. Autologous blood donation. Crit Care 2004;8(Suppl 2):S49-S52.
15. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000;96:823-33.
16. Kasper SM, Gerlich W, Buzello W. Preoperative red cell production in patients undergoing weekly autologous blood donation. Transfusion 1997;37:1058-62.
17. Kasper SM, Lazansky H, Stark C, et al. Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation. Transfusion 1998;38:764-70.
18. Weisbach V, Skoda P, Rippel R, et al. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: A randomized, controlled study. Transfusion 1999;39:465-72.
19. Goodnough LT, Price TH, Rudnick S, Soegiarso RW. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992;32:441-5.
20. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin: A controlled trial. N Engl J Med 1989;321:1163-8.
21. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: Dose, response, toxicity, and efficacy. Transfusion 1994;34:66-71.
22. Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986;26:335-40.
23. McVay PA, Andrews A, Kaplan EB, et al. Donation reactions among autologous donors. Transfusion 1990;30:249-52.
24. Tasaki T, Ohto H. Nineteen years of experience with autotransfusion for elective surgery in children: More troublesome than we expected. Transfusion 2007;47:1503-9.
25. Newman B, Tommolino E, Andreozzi C, et al. The effect of a 473mL (16-oz) water drink on vasovagal donor reaction rates in highschool students. Transfusion 2007;47:1524-33.
26. Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: An analysis of 10 years' experience. Transfusion 2000;40:1207-13.
27. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: Part II: Blood conservation. N Engl J Med 1999;340:525-33.
28. Faris PM, Ritter MA. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia. Clin Orthop Relat Res 1998;357:60-7.
29. Laupacis A, Feagan B, Wong C. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. COPES Study Group. Lancet 1993;342:378.
30. Faris PM, Ritter MA, Abels RI. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 1996;781:62-72.
31. de Andrade JR, Jove M, Landon G, et al. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;25:533-42.
32. Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996;25:544-52.
33. Sowade O, Warnke H, Scigalla P, et al. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997;89:411-8.
34. D'Ambra MN, Gray RJ, Hillman R, et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thora Surg 1997;64:1686-93.
35. Monk TG, Goodnough LT, Brecher ME, et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999;9:24-33.
36. Karkouti K, McCluskey SA, Evans L, et al. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth 2005;52:362-8.
37. Wong CJ, Vandervoort MK, Vandervoort SL, et al. A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplasty. Transfusion 2007;47:832-41.
38. Goodnough L. Preoperative management and preparation for transfusion-free surgery. In: Jabbour N, ed. Transfusion-free medicine and surgery. 1st ed. Oxford: Blackwell; 2005:60-74.
39. Fergusson DA, Hebert P The health(y) cost of erythropoietin in orthopedic surgery. Can J Anaesth 2005;52:347-51.
40. Cooley DA, Beall AC Jr, Grondin P. Open-heart operations with disposable oxygenators, 5 per cent dextrose prime, and normothermia. Surgery 1962;52:713-9.
41. Petry AF, Jost T, Sievers H. Reduction of homologous blood requirements by blood-pooling at the onset of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:1210-4.
42. Goodnough LT, Monk TG, Brecher ME. Autologous blood procurement in the surgical setting: Lessons learned in the last 10 years. Vox Sang 1996;71:133-41.
43. Brecher ME, Rosenfeld M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994;34:176-9.
44. Goodnough LT, Monk TG, Brecher ME. Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurement. Transfusion 1998;38:473-6.
45. Weiskopf RB. Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology 2001;94:439-46.
46. Shander A, Rijhwani TS. Acute normovolemic hemodilution. Transfusion 2004;44(Suppl):26S-34S.
47. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. Preoperative acute normovolemic hemodilution: A meta-analysis. Transfusion 2004;44:632-44.
48. Bennett J, Haynes S, Torella F, et al. Acute normovolemic hemodilu- tion in moderate blood loss surgery: A randomized controlled trial. Transfusion 2006;46:1097-103.
49. Sanders G, Mellor N, Rickards K, et al. Prospective randomized controlled trial of acute normovolaemic haemodilution in major gastrointestinal surgery. Br J Anaesth 2004;93:775-81.
50. Casati V, Benussi S, Sandrelli L, et al. Intraoperative moderate acute normovolemic hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg 2004;98:1217-23.
51. Shander A, Perelman S. The long and winding road of acute normovolemic hemodilution. Transfusion 2006;46:1075-9.
52. Waters JH. Indications and contraindications of cell salvage. Transfusion 2004;44(Suppl):40S-4S.
53. Freischlag JA. Intraoperative blood salvage in vascular surgery- worth the effort? Crit Care 2004;8(Suppl):S53-S56.
54. Carless PA, Henry DA, Moxey AJ, et al. Cell-salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006;(4):1-109.
55. Davies L, Brown TJ, Haynes S, et al. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion. Health Technol Assess 2006;10:1-228.
56. Waters J, Cheng D, Shande A, et al, eds. Perioperative blood management. 1st edition. Bethesda, MD: AABB, 2006:64.
57. Zulim RA, Rocco M, Goodnight JE, et al. Intraoperative autotransfusion in hepatic resection for malignancy: Is it safe? Arch Surg 1993;128:206-11.
58. Klimberg I, Sirois R, Wajsman Z, Baker J. Intraoperative autotransfusion in urologic oncology. Arch Surg 1986;121:1326-9.
59. Hart OJ, III, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet 1989;168:302-6.
60. Dzik WH, Sherburne B. Intraoperative blood salvage: Medical controversies. Transfus Med Rev 1990;4:208-35.
61. Hansen E, Pawlik M. Reasons against the retransfusion of unwashed wound blood. Transfusion 2004;44(Suppl):45S-53S.
62. Sinardi D, Marino A, Chillemi S, et al. Composition of the blood sampled from surgical drainage after joint arthroplasty: Quality of return. Transfusion 2005;45:202-7.
63. Dalen T, Bengtsson A, Brorsson B, Engstrom KG. Inflammatory mediators in autotransfusion drain blood after knee arthroplasty, with and without leucocyte reduction. Vox Sang 2003;85:31-9.
64. Duchow J, Ames M, Hess T, Seyfert U. Activation of plasma coagulation by retransfusion of unwashed drainage blood after hip joint arthroplasty: A prospective study. J Arthroplasty 2001;16:844-9.
65. Waters JH, Dyga RM. Postoperative blood salvage: Outside the controlled world of the blood bank. Transfusion 2007;47:362-5.
66. Moonen AF, Knoors NT, van Os JJ, et al. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: A prospective randomized clinical trial. Transfusion 2007;47:379-84.